Peptide vaccine trials for melanoma: preclinical background and clinical results

Semin Cancer Biol. 2003 Dec;13(6):431-8. doi: 10.1016/j.semcancer.2003.09.007.
No abstract available

Publication types

  • Review

MeSH terms

  • Antigens, Neoplasm
  • Histocompatibility Antigens Class I / immunology
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • Melanoma / immunology*
  • Melanoma / therapy*
  • Melanoma-Specific Antigens
  • Neoplasm Proteins / immunology*
  • Skin Neoplasms / immunology*
  • T-Lymphocytes / immunology*
  • Vaccines, Subunit / immunology*

Substances

  • Antigens, Neoplasm
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • Melanoma-Specific Antigens
  • Neoplasm Proteins
  • Vaccines, Subunit